Back
Range Cancer Therapeutics ETF Vs. Invesco Nasdaq Biotechnology ETF Industry Stock Comparison
Buy
63
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.58
Seasonality Move:
8.86%
Sell
48
IBBQ
Invesco Nasdaq Biotechnology ETF
Last Price:
24.36
Seasonality Move:
3.31%
Buy
63
Range Cancer Therapeutics ETF (CNCR)
is a Buy
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.59. The Score for CNCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- CNCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Invesco Nasdaq Biotechnology ETF (IBBQ)
is a Sell
Is Invesco Nasdaq Biotechnology ETF a Buy, Sell or Hold?
- The current Invesco Nasdaq Biotechnology ETF [IBBQ] share price is $23.99. The Score for IBBQ is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- IBBQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight selling pressure.
IBBQ Stock Price Chart
What is Invesco Nasdaq Biotechnology ETF's stock price today?
-
The Invesco Nasdaq Biotechnology ETF share price today is $23.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBBQ is experiencing slight selling pressure.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 59.34 | Buy |
| Chaikin Money Flow: | -127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.63 - 15.23) | Buy |
| Bollinger Bands (100): | (14 - 15.38) | Buy |
IBBQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 56.07 | Buy |
| Chaikin Money Flow: | -1961 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.38 - 23.94) | Buy |
| Bollinger Bands (100): | (23.12 - 24.3) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.03 | Buy |
| 20-day SMA: | 15 | Buy |
| 50-day SMA: | 15.01 | Buy |
| 200-day SMA: | 15.06 | Buy |
| 8-day EMA: | 15.09 | Buy |
| 20-day EMA: | 15.01 | Buy |
| 50-day EMA: | 14.94 | Buy |
| 200-day EMA: | 14.59 | Buy |
IBBQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.63 | Buy |
| 20-day SMA: | 23.73 | Buy |
| 50-day SMA: | 23.86 | Buy |
| 200-day SMA: | 22.81 | Buy |
| 8-day EMA: | 23.68 | Buy |
| 20-day EMA: | 23.69 | Buy |
| 50-day EMA: | 23.73 | Buy |
| 200-day EMA: | 22.89 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Invesco Nasdaq Biotechnology ETF Earnings Growth & IBBQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Invesco Nasdaq Biotechnology ETF Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||